Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes.
Kuhadiya, Nitesh D
Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes. [electronic resource] - Diabetes, obesity & metabolism 04 2019 - 1054-1057 p. digital
Publication Type: Journal Article
1463-1326
10.1111/dom.13609 doi
Adult
Autoantibodies--immunology
Body Weight
C-Peptide--metabolism
Deprescriptions
Diabetes Mellitus, Type 1--drug therapy
Drug Therapy, Combination
Female
Glucagon-Like Peptides--analogs & derivatives
Glutamate Decarboxylase--immunology
Glycated Hemoglobin--metabolism
Humans
Hypoglycemic Agents--therapeutic use
Immunoglobulin Fc Fragments--therapeutic use
Insulin--therapeutic use
Liraglutide--therapeutic use
Male
Middle Aged
Recombinant Fusion Proteins--therapeutic use
Retrospective Studies
Treatment Outcome
Weight Loss
Glucagon-Like Peptide-1 Receptor Agonists
Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes. [electronic resource] - Diabetes, obesity & metabolism 04 2019 - 1054-1057 p. digital
Publication Type: Journal Article
1463-1326
10.1111/dom.13609 doi
Adult
Autoantibodies--immunology
Body Weight
C-Peptide--metabolism
Deprescriptions
Diabetes Mellitus, Type 1--drug therapy
Drug Therapy, Combination
Female
Glucagon-Like Peptides--analogs & derivatives
Glutamate Decarboxylase--immunology
Glycated Hemoglobin--metabolism
Humans
Hypoglycemic Agents--therapeutic use
Immunoglobulin Fc Fragments--therapeutic use
Insulin--therapeutic use
Liraglutide--therapeutic use
Male
Middle Aged
Recombinant Fusion Proteins--therapeutic use
Retrospective Studies
Treatment Outcome
Weight Loss
Glucagon-Like Peptide-1 Receptor Agonists